Non-hodgkins lymphoma - Has anybody had a severe, red, & itchy rash that wont go away even after rchop and radiation...

May 30, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

non-hodgkins lymphoma - Has anybody had a severe, red, & itchy rash that wont go away even after rchop and radiation is all over? If so, what are some things that helped?

Managing Persistent Rash After NHL Treatment

I understand you're dealing with a stubborn rash that's persisted even after completing your RCHOP chemotherapy and radiation therapy. This is a real concern, and I want to help you think through what might be happening and what questions to ask your care team.

Understanding Post-Treatment Skin Issues in NHL Patients

After aggressive treatments like RCHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) and radiation, your skin can experience several different types of reactions:

Common causes of persistent rashes after NHL treatment include:

  • Radiation dermatitis – Skin irritation from radiation that can persist weeks to months after treatment ends, especially if the rash is in the radiation field
  • Chemotherapy-related skin reactions – Some chemotherapy drugs cause delayed skin sensitivity or inflammatory responses
  • Medication reactions – Supportive medications used during treatment (antibiotics, antiemetics, etc.) can cause delayed rashes
  • Infection or fungal overgrowth – Immunosuppression during treatment can allow secondary infections
  • Skin barrier damage – Treatments can compromise your skin's protective function, leading to chronic irritation
  • Pruritus (itching) – A known side effect that can persist independently of visible rash

According to NCCN Guidelines for Patients with Non-Hodgkin Lymphomas, managing side effects after treatment completion is an important part of your care plan, though specific guidance on persistent rashes focuses on prevention during active treatment rather than post-treatment management.

What You Should Do Now

This rash needs evaluation by your care team because:

  1. Timing matters – How long has it been since your last radiation treatment? (Radiation dermatitis typically peaks 1-2 weeks after treatment but can persist)
  2. Location matters – Is it in the radiation field, or elsewhere on your body?
  3. Characteristics matter – Red, itchy rashes can have very different causes requiring different treatments

Specific questions to ask your oncology team:

  1. "Is this rash consistent with radiation dermatitis, or does it suggest something else like an infection or medication reaction?"

    • They may want to examine it or take a skin sample (biopsy) to rule out infection or other causes
  2. "Should I see a dermatologist, or can you manage this in oncology?"

    • Many cancer centers have dermatologists experienced with treatment-related skin issues
  3. "What topical treatments are safe for me right now, given my recent chemotherapy and radiation?"

    • Some common treatments (like certain steroids or antibiotics) may interact with your recovery
  4. "Could this be related to my immune system recovering from treatment?"

    • Sometimes rashes appear as your immune system rebounds (called immune reconstitution)
  5. "Are there any oral medications that could help if topical treatments aren't working?"

    • Options might include antihistamines, low-dose steroids, or other medications depending on the cause

Evidence-Based Approaches That May Help

While I don't have specific patient outcome data on post-NHL rash management in my sources, general oncology supportive care (per NCCN Guidelines) includes:

  • Gentle skin care – Avoid irritants, use fragrance-free products, keep skin moisturized
  • Avoiding triggers – Hot water, tight clothing, sun exposure can worsen radiation dermatitis
  • Topical treatments – Your doctor may recommend specific creams (hydrocortisone, calcineurin inhibitors, or others)
  • Infection prevention – Keep the area clean to prevent secondary bacterial or fungal infections

Important Distinction: Your Care Team's Role

Your oncologist and/or dermatologist need to determine:

  • Whether this is a known treatment side effect vs. something new
  • Whether it requires treatment or will resolve on its own
  • Whether it could indicate a complication (like infection)
  • What's safe to use given your recent intensive treatment

This is especially important because your immune system is still recovering from RCHOP and radiation, so treatments need to be carefully chosen.

Connecting With Others

Since you mentioned having problems with City of Hope, I want to acknowledge that navigating care can be frustrating. The Lymphoma Research Foundation (lymphoma.org) has patient support resources and may connect you with others who've experienced similar post-treatment skin issues. They can provide peer support and practical advice from people who've been through similar situations.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your oncology team or dermatologist is the right person to evaluate this rash, determine its cause, and recommend safe treatment options for your specific situation.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:

Related Questions

Non-hodgkins lympoma: Day 7 post-infusion is the WORST. I put it on my calendar. Schedule NOTHING on Day 7....

Thank you for sharing this important insight about your treatment timeline. What you're describing is a very real and documented pattern with Pola-R-C

Repurposed drug schedule for metastatic breast cancer

I'd be happy to help you understand repurposed drugs medications originally developed for other conditions that are now used in cancer treatment for m

Follicular lymphoma: There are people who have undergone four lines of treatment... because there have been...

I appreciate you sharing this concern about follicular lymphoma and treatment failures. However, I notice your message seems to reference a general qu

What lifestyle changes are recommended for null patients

I appreciate you sharing that context, but I notice the patient medical profile section is empty — it shows "PATIENT MEDICAL CONTEXT - Use this to per

What published data support R-CEP in DLBCL? 2. How many patients with DLBCL have they treated with it? 3. Is the...

I appreciate you asking me to be more precise. Let me be direct about what I actually know versus what I don't: 1. Published Data Supporting R-CEP i

What published data support R-CEP in DLBCL? 2. How many patients with DLBCL have they treated with it? 3. Is the...

I appreciate your detailed questions about R-CEP rituximab, cyclophosphamide, epirubicin, prednisone in DLBCL. Let me address what the published evide

What side effects should I expect from treatment

Based on your medical profile, you're currently on chemotherapy and targeted therapy erlotinib following radiation for spinal cord compression. Let me

The patient recently underwent a CT scan prior to her clinic visit. The key findings include: Left Kidney Tumor:...

Thank you for sharing these detailed imaging results and clinical information. I can see this presents a complex picture—significant imaging findings